Silexion Therapeutics Corp

Developing a local drug delivery platform to treat KRAS-driven cancers and solid tumors.

SLXN | US

Overview

Corporate Details

ISIN(s):: KYG1281K1141 (+1 more)
LEI:
Country:: United States of America
Address:: 12 ABBA HILLEL ROAD, 5250606 RAMAT GAN
Website:: https://www.moringaac.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers and other solid tumors, such as pancreatic cancer. The company's core technology is its proprietary LODER (Local Drug Eluter) drug delivery platform. This platform is designed to provide local and prolonged delivery of therapeutic agents directly within the tumor core, aiming to solve significant drug delivery challenges and improve outcomes for patients with hard-to-treat cancers. Silexion is also developing innovative RNA-based therapeutics and collaborates with industry partners to advance its clinical manufacturing and formulation development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Silexion Therapeutics Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Silexion Therapeutics Corp

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Silexion Therapeutics Corp via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Biotech firm developing cell therapies for regenerative medicine and immunotherapy applications.	United States of America	CELZ
CRESCENT BIOPHARMA, INC. A biotech company developing bispecific antibody therapies to treat solid tumors.	United States of America	CBIO
Crinetics Pharmaceuticals, Inc. Develops novel therapeutics for rare endocrine diseases and related tumors.	United States of America	CRNX
CRISPR Therapeutics AG Develops transformative CRISPR gene-based medicines for diseases like sickle cell.	United States of America	CRSP
Crossject Develops needle-free auto-injectors for rapid drug delivery in medical emergencies.	France	ALCJ
CTC BIO, INC. Develops pharmaceuticals and feed additives for human and animal health using fermentation tech.	South Korea	060590
Cue Biopharma, Inc. Develops injectable biologics to selectively activate T cells for oncology & autoimmune disease.	United States of America	CUE
Cullinan Therapeutics, Inc. Developing differentiated immune-modulating therapies for cancer and autoimmune diseases.	United States of America	CGEM
CUMBERLAND PHARMACEUTICALS INC Acquires and commercializes branded medicines for acute care, gastroenterology, and oncology.	United States of America	CPIX
Cuorips Inc. Develops iPS cell therapies, like a cardiomyocyte sheet for severe heart failure.	Japan	4894